A research team led by Stanford University has successfully created a synthetic virus not found in nature using generative AI technology. While this advancement could aid in controlling deadly bacteria, experts warn that it significantly increases the risk of developing biological weapons. Specialists emphasize that current government regulations are insufficient due to the lack of adequate security policies for controlling generative genomics.
Kathmandu, August 7 – The Stanford-led research group has utilized generative AI to develop synthetic viruses for the first time, creating entirely novel organisms never before seen in nature. AI experts caution that this breakthrough introduces potential risks for future biohazards. Existing surveillance systems are inadequate for monitoring these pathogens, which have been confirmed to evolve at a rapid pace.
This research is also expected to bring substantial progress in the medical field. In a paper published in the journal Science, the team stated, “The full potential of genome language models to create functioning genomes is still under evaluation.” They designed AI models that can infect and destroy E. coli bacteria, potentially offering a powerful tool to control lethal bacterial infections.
However, this technology carries the risk of being misused to develop more complex life forms and biological weapons. The report underscores the need for a new governmental approach to regulate high-risk research. Previously, the Trump administration introduced regulations addressing “gain of function” research on natural pathogens. Senator Rand Paul’s committee had accused Dr. Anthony Fauci of withholding cooperation on investigations into the origins of the COVID-19 pandemic. Yet, the creation of wholly new viruses via generative AI exceeds the scope of any prior studies.
Though laws and regulatory bodies govern biotechnology, innovation often progresses faster than regulations can keep up. Last month, the Trump administration issued policies to halt federally funded high-risk life sciences research, banning gain-of-function studies and calling for stricter oversight of biological hazard agents. However, these policies have yet to address AI-driven research adequately.
The research is advancing rapidly. Health security experts Thomas Inglesby and Moritz Henke from Johns Hopkins wrote in the same Science issue that the Stanford team deserves praise for exercising caution. Nevertheless, they highlight the significant risks posed by the absence of a proper regulatory framework for generative genomics. “The capability to generate viral genomes using generative AI is now available, but the government lacks regulations to operate this safely,” they emphasized.
